PeproTech is proud to be able to continue to support you in the midst of unprecedented challenges pertaining to the COVID-19 virus. For more information, click here.

Research Areas


COVID-19 (SARS-CoV-2) has become a global concern and a center of interest for the scientific community, which is researching the virus from many different perspectives. PeproTech's products are frequently cited in publications exploring COVID-19 research, from its infection mechanisms to its response to anti-COVID-19 drugs. Below we have compiled a collection of COVID-19 related articles, which give insight into some of the progress being made, and a listing of the relevant products cited within these articles.

View References for PeproTech’s products in COVID-19 Research:

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells 

Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium Cell Stem Cell 

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2 

Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses 

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity 

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels 

Explore relevant products below.